Pensabene and O’Boyle to Discuss Paragraph IV Litigation at ACI EventApril 23, 2018
O’Melveny partner Lisa Pensabene and counsel Dan O’Boyle will speak at American Conference Institute’s 12th annual Paragraph IV Disputes conference on April 23, 2018, in New York.
Pensabene will co-moderate the panel, “The Federal Judges Speak on Paragraph IV Litigation.” The discussion will ask distinguished jurists with some of the liveliest Paragraph IV litigation dockets in the country to examine decision-making practices employed by the judicial system and provide advice for both patent holders and patent challengers.
O’Boyle will speak on the panel, “A Closer Look at Dispositive Motions: An In-Depth Discussion of Summary Judgment and Declaratory Judgments Motions for Brand Names and Generics.” The panel will cover such topics as assessing the probability of success for a declaratory judgment motion, identifying circumstances when summary judgment is the best option, and addressing dispositive motion practice with multiple ANDA filers.
Pensabene, head of the O’Melveny’s Life Science Litigation practice, handles high stakes patent litigation in the pharmaceutical and chemical industries. A first chair trial lawyer, she has led more than 20 major pharmaceutical and chemical patent litigations, leading cases in bench and jury trials, arguing to the Federal Circuit, and leading briefing to the US Supreme Court.
O’Boyle is a skilled litigator specializing in intellectual property and technology law. He regularly represents pharmaceutical manufacturers and chemical companies in patent litigation matters, among other intellectual property issues.
Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.